• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体腓肠神经组织移植入人脑后的受体反应及组成

Recipient Reaction and Composition of Autologous Sural Nerve Tissue Grafts into the Human Brain.

作者信息

Colvett Isaac, Gilmore Anah, Guzman Samuel, Ledreux Aurélie, Quintero Jorge E, Ginjupally Dhanunjaya Rao, Gurwell Julie A, Slevin John T, Guduru Zain, Gerhardt Greg A, van Horne Craig G, Granholm Ann-Charlotte

机构信息

Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

J Clin Med. 2023 Sep 22;12(19):6121. doi: 10.3390/jcm12196121.

DOI:10.3390/jcm12196121
PMID:37834764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10573749/
Abstract

Parkinson's disease (PD) is a severe neurological disease for which there is no effective treatment or cure, and therefore it remains an unmet need in medicine. We present data from four participants who received autologous transplantation of small pieces of sural nerve tissue into either the basal forebrain containing the nucleus basalis of Meynert (NBM) or the midbrain substantia nigra (SN). The grafts did not exhibit significant cell death or severe host-tissue reaction up to 55 months post-grafting and contained peripheral cells. Dopaminergic neurites showed active growth in the graft area and into the graft in the SN graft, and cholinergic neurites were abundant near the graft in the NBM. These results provide a histological basis for changes in clinical features after autologous peripheral nerve tissue grafting into the NBM or SN in PD.

摘要

帕金森病(PD)是一种严重的神经疾病,目前尚无有效的治疗方法或治愈手段,因此仍是医学上未被满足的需求。我们展示了四名参与者的数据,他们接受了将小块腓肠神经组织自体移植到含有Meynert基底核(NBM)的基底前脑或中脑黑质(SN)的手术。移植后长达55个月,移植物未表现出明显的细胞死亡或严重的宿主组织反应,且含有外周细胞。多巴胺能神经突在移植区域有活跃生长,并在SN移植物中长入移植物,胆碱能神经突在NBM移植物附近丰富。这些结果为PD患者将自体周围神经组织移植到NBM或SN后临床特征的变化提供了组织学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/5a3b2f03e068/jcm-12-06121-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/24380519f5ab/jcm-12-06121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/ecfa9bc89781/jcm-12-06121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/6dba6c10fdfc/jcm-12-06121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/7e696fa4b660/jcm-12-06121-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/5a3b2f03e068/jcm-12-06121-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/24380519f5ab/jcm-12-06121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/ecfa9bc89781/jcm-12-06121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/6dba6c10fdfc/jcm-12-06121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/7e696fa4b660/jcm-12-06121-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ae2/10573749/5a3b2f03e068/jcm-12-06121-g005.jpg

相似文献

1
Recipient Reaction and Composition of Autologous Sural Nerve Tissue Grafts into the Human Brain.自体腓肠神经组织移植入人脑后的受体反应及组成
J Clin Med. 2023 Sep 22;12(19):6121. doi: 10.3390/jcm12196121.
2
Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.在脑深部电刺激手术中,将周围神经移植物植入帕金森病患者的黑质中:安全性、可行性和临床结果的 1 年随访研究。
J Neurosurg. 2018 Dec 1;129(6):1550-1561. doi: 10.3171/2017.8.JNS163222. Epub 2018 Feb 18.
3
Nucleus basalis of Meynert neuronal activity in Parkinson's disease.帕金森病中的基底核梅内尔特神经元活动。
J Neurosurg. 2019 Feb 22;132(2):574-582. doi: 10.3171/2018.11.JNS182386. Print 2020 Feb 1.
4
Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.一名帕金森病伴痴呆患者出现妄想和视幻觉,其核基底节 Meynert 中Lewy 体病变明显。
Neuropathology. 2019 Aug;39(4):319-323. doi: 10.1111/neup.12581. Epub 2019 Jun 26.
5
Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease.步态变化与基底核梅内尔特核的萎缩有关,并且对帕金森病中的 STN DBS 有抗性。
Neurobiol Dis. 2020 Dec;146:105134. doi: 10.1016/j.nbd.2020.105134. Epub 2020 Oct 10.
6
Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson's disease treated with bilateral STN DBS: a report of safety and feasibility.将自体周围神经移植物植入接受双侧 STN DBS 治疗的特发性帕金森病患者的黑质中:安全性和可行性报告。
J Neurosurg. 2017 Apr;126(4):1140-1147. doi: 10.3171/2016.2.JNS151988. Epub 2016 May 6.
7
Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson's disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial.丘脑底核与Meynert基底核联合深部脑刺激治疗帕金森病痴呆(DEMPARK-DBS):一项随机、假手术对照试验方案
Neurol Res Pract. 2020 Oct 19;2:41. doi: 10.1186/s42466-020-00086-w. eCollection 2020.
8
Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease.基底核梅内尔特退化预测帕金森病的认知障碍。
Handb Clin Neurol. 2021;179:189-205. doi: 10.1016/B978-0-12-819975-6.00010-8.
9
Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy.基底前脑萎缩的帕金森病的临床和脑代谢变化。
Mov Disord. 2020 May;35(5):825-832. doi: 10.1002/mds.27988. Epub 2020 Jan 23.
10
Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.胚胎腹侧中脑移植到经MPTP处理的猴子黑质:作为帕金森病治疗方法的多靶点移植的可行性
J Comp Neurol. 2002 Jan 21;442(4):320-30. doi: 10.1002/cne.10108.

本文引用的文献

1
Mapping Cholinergic Synaptic Loss in Parkinson's Disease: An [18F]FEOBV PET Case-Control Study.帕金森病胆碱能突触缺失的定位:[18F]FE-OBV PET 病例对照研究。
J Parkinsons Dis. 2022;12(8):2493-2506. doi: 10.3233/JPD-223489.
2
Using a Transection Paradigm to Enhance the Repair Mechanisms of an Investigational Human Cell Therapy.利用横断范式增强一种实验性人细胞治疗的修复机制。
Cell Transplant. 2022 Jan-Dec;31:9636897221123515. doi: 10.1177/09636897221123515.
3
Direct delivery of an investigational cell therapy in patients with Parkinson's disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design.
帕金森病患者直接接受研究性细胞疗法:采用DBS-Plus临床试验设计的开放标签研究的可行性和安全性中期分析
BMJ Neurol Open. 2022 Jul 14;4(2):e000301. doi: 10.1136/bmjno-2022-000301. eCollection 2022.
4
Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model.人类中脑多巴胺能神经元分化标志物可预测帕金森病模型中的细胞治疗效果。
J Clin Invest. 2022 Jul 15;132(14). doi: 10.1172/JCI156768.
5
Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.单基因帕金森病:基因型、表型、病理生理学及基因检测
Genes (Basel). 2022 Mar 7;13(3):471. doi: 10.3390/genes13030471.
6
The secretion profile of mesenchymal stem cells and potential applications in treating human diseases.间充质干细胞的分泌谱及其在治疗人类疾病中的潜在应用。
Signal Transduct Target Ther. 2022 Mar 21;7(1):92. doi: 10.1038/s41392-022-00932-0.
7
Four Seasons for Schwann Cell Biology, Revisiting Key Periods: Development, Homeostasis, Repair, and Aging.施旺细胞生物学的四季:重温关键时期:发育、稳态、修复和衰老。
Biomolecules. 2021 Dec 15;11(12):1887. doi: 10.3390/biom11121887.
8
Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia.胶质细胞源性神经营养因子家族配体:神经炎症与神经保护界面的参与者——聚焦于神经胶质细胞
Front Cell Neurosci. 2021 Jun 17;15:679034. doi: 10.3389/fncel.2021.679034. eCollection 2021.
9
Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain.帕金森病中的神经营养因子:临床试验、公开挑战及纳米颗粒介导的脑内递送
Front Cell Neurosci. 2021 Jun 2;15:682597. doi: 10.3389/fncel.2021.682597. eCollection 2021.
10
Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors.帕金森病中的认知障碍:流行病学、临床特征、保护因素和风险因素。
Behav Sci (Basel). 2021 May 13;11(5):74. doi: 10.3390/bs11050074.